Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Roche
Company Monitoring Page for Roche
latest headlines for company on cafepharma
After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl
Fierce Pharma
Thu, 03/17/22 - 10:38 am
Tags:
AstraZeneca
,
Roche
,
Chugai
,
Ultomiris
,
patents
Aiming to drug genetic modifiers, Roche-partnered biotech bags $31M to fuel a drive toward clinic
Endpoints
Thu, 03/10/22 - 10:27 am
Tags:
Scenic Biotech
,
Roche
,
Genentech
,
genetic modifiers
A trio of amyloid-targeted Alzheimer's drugs will soon see key results, but an analyst predicts only 50-50 odds for one
Endpoints
Wed, 03/9/22 - 11:09 pm
Tags:
Alzheimer's disease
,
clinical trials
,
Roche
,
Eli Lilly
,
Biogen
,
donanemab
,
lecanemab
,
gantenerumab
Sanofi, scarred by Roche scrap, hits goal in once-weekly hemophilia A trial and plots race to regulators
Fierce Biotech
Wed, 03/9/22 - 10:54 am
Tags:
Sanofi
,
Roche
,
Sobi
,
hemophilia A
,
clinical trials
Roche starts new four-year trial of Alzheimer’s drug gantenerumab
Pharmaforum
Fri, 03/4/22 - 09:48 am
Tags:
Roche
,
Alzheimer's disease
,
clinical trials
,
gantenerumab
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
Fierce Pharma
Thu, 03/3/22 - 10:33 am
Tags:
FDA
,
drug approvals
,
FibroGen
,
AstraZeneca
,
daprodustat
,
Bristol Myers Squibb
,
Opdivo
,
Roche
,
tiragolumab
,
Merck
,
favezelima
,
bInnovent
,
Eli Lilly
,
Akeso Biopharma
,
Sino Biopharmaceutical
,
Novartis
,
Ukoniq
,
TG Therapeutics
,
GW Pharmaceuticals
,
Marinus Pharmaceuticals
Roche steps up with a free supply of antibiotics for Ukraine as drug donations begin to flow
Endpoints
Wed, 03/2/22 - 10:06 pm
Tags:
Roche
,
Ukraine
,
Rocephin
Roche's Foundation Medicine gets FDA breakthrough device nod in latest designations
Medtech Dive
Mon, 02/28/22 - 09:34 am
Tags:
Roche
,
Foundation Medicine
,
diagnostics
,
tumor DNA
,
breakthrough designations
,
Medtech
Roche's gene therapy unit finds a new Spark as co-founding CEO makes way for new leader
Fierce Biotech
Wed, 02/23/22 - 10:28 pm
Tags:
Roche
,
gene therapy
,
Spark Therapeutics
,
Jeffrey D. Marrazzo
,
Ron Philip
Roche and AstraZeneca settle years long patent battle over Ultomiris — report
Endpoints
Sun, 02/20/22 - 11:48 am
Tags:
Roche
,
Chugai
,
AstraZeneca
,
Alexion
,
patents
,
Ultomiris
,
Soliris
Covid infects biopharma’s biggest sellers
EP Vantage
Thu, 02/17/22 - 10:45 am
Tags:
Pfizer
,
AstraZeneca
,
vaccines
,
COVID-19
,
Roche
Roche-backed biotech refuels with $40M to steer neuromuscular candidate toward late-stage trials
Endpoints
Tue, 02/15/22 - 10:27 am
Tags:
NMD Pharma
,
Roche
,
neuromuscular disease
,
funding
Eli Lilly and Roche ask CMS not to be lumped in with Aduhelm’s restrictive judgment
Endpoints
Mon, 02/14/22 - 11:06 am
Tags:
Eli Lilly
,
Roche
,
Biogen
,
Alzheimer's disease
,
Aduhelm
,
CMS
The biggest launches of 2022: a reboot
EP Vantage
Mon, 02/14/22 - 10:48 am
Tags:
drug launches
,
Eli Lilly
,
tirzepatide
,
Alnylam
,
vutrisiran
,
Roche
,
Vabysmo
,
JNJ
,
Carvykti
,
Mirati Therapeutics
,
adagrasib
,
Bristol Myers Squibb
,
mavacamten
,
deucravacitinib
Vas Narasimhan and Severin Schwan each claimed pay packets worth $12M+ for 2021
Endpoints
Sat, 02/12/22 - 11:49 pm
Tags:
Roche
,
Novartis
,
executive pay
,
Severin Schwan
,
Vas Narasimhan
Roche pharma CEO Anderson talks up Vabysmo’s 'very strong launch' plans as Eylea battle looms
Fierce Pharma
Wed, 02/9/22 - 10:56 pm
Tags:
Roche
,
Vabysmo
,
drug launches
,
Bill Anderson
,
Eylea
Chasing Novartis and Roche, Ventus banks $140M to take inflammatory disease drug into the clinic
Fierce Biotech
Wed, 02/9/22 - 10:07 am
Tags:
Ventus Therapeutics
,
Novartis
,
Roche
,
funding
,
inflammation
Endeavor Bio adds $101M to test ex-Eli Lilly, Roche drug in cancer & lung fibrosis
MedCity News
Tue, 02/8/22 - 09:52 am
Tags:
Endeavor BioMedicines
,
taladegib
,
cancer
,
Eli Lilly
,
Roche
,
idiopathic pulmonary fibrosis
Roche, Novartis CEOs pull down $12M-plus each in 2021 pay
Fierce Pharma
Thu, 02/3/22 - 11:22 pm
Tags:
Roche
,
exeuctiva pay
Roche regains pre-pandemic sales footing, highlights bursting pipeline — with one key failure
Endpoints
Thu, 02/3/22 - 11:09 pm
Tags:
Roche
,
earnings
,
pandemic
Pages
« first
‹ previous
…
15
16
17
18
19
20
21
22
23
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.